Mortality in Pregnant Women with COVID-19 in Mexico

Authors

  • Michelle Arias-Morales Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico and School of Medicine, Quetzalcoatl University in Irapuato, Mexico.
  • Edith Fernanda Villanueva Mendez Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico and School of Medicine, Quetzalcoatl University in Irapuato, Mexico.
  • Luis Ignacio Pérez-Velázquez Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico and Division of Health Sciences, Campus Leon, University of Guanajuato, Mexico.
  • Maria de Jesús Gallardo-Luna Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.
  • Gilberto Flores-Vargas Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.
  • Efraín Navarro-Olivos Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.
  • Nicolás Padilla-Raygoza Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.

DOI:

https://doi.org/10.9734/bpi/nramms/v5/1365G

Keywords:

COVID-19, fatality, pregnancy, reproductive age, SARS-CoV-2, surveillance system

Abstract

During the pandemic by SARS-CoV-2 the pregnant women, people older than 60 years, lung problems (asthma, COPD), heart disease, brain and nervous system conditions, cancer and certain blood disorders, weakened immune system, chronic kidney, liver disease, mental health condition, down syndrome and kids under 5 years are considered a group of risk, although pregnant women infected with SARS-COV-2 are predominantly asymptomatic or present mild COVID-19 very similar to non-pregnant women. The aim is review the mortality by COVID-19 in pregnant women in Mexico.

Sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that are more similar to bats coronavirus than human SARS.  COVID-19 starts as a pneumonia case with unfamiliar etiology and origin, The coronavirus disease 19 is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2. Genomic analysis revealed that SARS-CoV-2 is phylogenetically related to severe acute respiratory syndrome-like (SARS-like) bat viruses, therefore bats could be the possible primary reservoir. Main symptoms reported in COVID 19: fever, dry cough, asthenia, myalgia, arthralgias, headache chills, odynophagia and dyspnea. Anosmia, ageusia, diarrhea, vomiting, nasal congestion and hemoptysis are less common.

According to different studies made in Mexico, there is no evidence that pregnant women are more susceptible to severe SARS-CoV-2 infection. However, they being considered as a population group at risk, it has been shown that comparing other comorbidities such as pneumonia, asthma, COPD and even the increase in age, they are susceptible to the increase mortality rate and complications in patients affected by COVID 19.

Published

2023-10-11

How to Cite

Michelle Arias-Morales, Edith Fernanda Villanueva Mendez, Luis Ignacio Pérez-Velázquez, Maria de Jesús Gallardo-Luna, Gilberto Flores-Vargas, Efraín Navarro-Olivos, & Nicolás Padilla-Raygoza. (2023). Mortality in Pregnant Women with COVID-19 in Mexico. Novel Research Aspects in Medicine and Medical Science Vol. 5, 119–132. https://doi.org/10.9734/bpi/nramms/v5/1365G